Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Efficacy of Zoledronic Acid in the Management of Osteoporosis in Children With Multiple Disabilities

NCT03301285 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT03301285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Efficacy of Zoledronic Acid in the Management of Osteoporosis in Children With Multiple Disabilities
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
March 31, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple disability, osteoporosis